Evaluate the Efficacy and Safety of Atorvastatin Combined With Temozolomide in the Treatment of Glioblastoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions

Glioblastoma, IDH-wildtype

Interventions

DRUG

Atorvastatin 20mg

Liptor is a capsule in the form of 20 mg, once daily.

Trial Locations (1)

RECRUITING

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors

lead

Tianjin Medical University General Hospital

OTHER